title: Co-administration of rifampin and nevirapine in HIV-infected patients with tuberculosis.
authors.forename: Jesús
authors.initials: J
authors.lastname: Oliva
authors.forename: Santiago
authors.initials: S
authors.lastname: Moreno
authors.forename: Jesús
authors.initials: J
authors.lastname: Sanz
authors.forename: Esteban
authors.initials: E
authors.lastname: Ribera
authors.forename: José A O
authors.initials: JA
authors.lastname: Molina
authors.forename: Rafael
authors.initials: R
authors.lastname: Rubio
authors.forename: Esperanza
authors.initials: E
authors.lastname: Casas
authors.forename: Ana
authors.initials: A
authors.lastname: Mariño
mesh_terms: D000328:Adult; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D000995:Antitubercular Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D019829:Nevirapine / Q000627:therapeutic use*; D012293:Rifampin / Q000627:therapeutic use*; D016896:Treatment Outcome; D014376:Tuberculosis / Q000150:complications / Q000188:drug therapy*
chemical_list: D019380:Anti-HIV Agents; D000995:Antitubercular Agents; D019829:Nevirapine; D012293:Rifampin